Dermata Therapeutics Inc
DRMA
Get informed when a big investor buys or sells
+ FollowMarket Cap$879.21K
Close$
$2.07
54.2% upside
Current Fair Value
54.2% upsideUndervalued by 54.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $879,209.00 |
|---|---|
| Enterprise Value | $-6,066,073.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-8.16 |
| Beta | 0.69 |
| Outstanding Shares | 3,858,921 |
Return
| Return on Equity | -110.75% |
|---|---|
| Return on Assets | -95.14% |
| Return on Invested Capital | -113.70% |
Valuation & Multiples
| P/E Ratio | -0.24 |
|---|---|
| PEG | 1.23 |
| Price to Sales | - |
| Price to Book Ratio | 1.34 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.83 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 20, 2026
EPS Estimate
$-0.53
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 18, 2026
EPS Estimate
$-0.55
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 2.76%▲ 0.56% |
|---|---|
| Total Invested | $128,853▲ 106.53% |
| Investors Holding | 70% |
ESG Score
No data
About Dermata Therapeutics Inc
2,021 employees